Giubbini R, Bertagna F
Eur J Nucl Med Mol Imaging. 2016; 43(8):1491-2.
PMID: 27178273
DOI: 10.1007/s00259-016-3416-3.
Heintzen M, Heidland U, Klimek W, Leschke M, Kelm M, Schwartzkopff B
Heart. 2000; 83(5):551-6.
PMID: 10768906
PMC: 1760836.
DOI: 10.1136/heart.83.5.551.
Heidland U, Klimek W, Michel C, Heintzen M, Strauer B
Med Klin (Munich). 1998; 93(10):579-84.
PMID: 9849048
DOI: 10.1007/BF03042672.
Cooper J, Hill S, Alexander S, Rubin P, Horn E
Br J Clin Pharmacol. 1995; 40(1):43-50.
PMID: 8527267
PMC: 1365026.
DOI: 10.1111/j.1365-2125.1995.tb04533.x.
Mitchell J
Br Med J. 1980; 280(6223):1128-30.
PMID: 7000236
PMC: 1601166.
DOI: 10.1136/bmj.280.6223.1128.
Prostaglandins in vascular disease: a seminal approach.
Mitchell J
Br Med J (Clin Res Ed). 1981; 282(6264):590-4.
PMID: 6781584
PMC: 1504467.
DOI: 10.1136/bmj.282.6264.590.
Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo.
EMMONS P, Hampton J, Harrison M, HONOUR A, Mitchell J
Br Med J. 1967; 2(5550):468-72.
PMID: 6023964
PMC: 1842033.
DOI: 10.1136/bmj.2.5550.468.
Potentiation of adenosine and the adenine nucleotides by dipyridamole.
Stafford A
Br J Pharmacol Chemother. 1966; 28(2):218-27.
PMID: 5972628
PMC: 1510865.
DOI: 10.1111/j.1476-5381.1966.tb01888.x.
Deep-vein thrombosis.
Br Med J. 1966; 2(5513):540-1.
PMID: 5917363
PMC: 1943807.
Action of a pyrimido-pyrimidine compound on platelet behaviour in vitro.
Forbes C, McNicol G, Douglas A
Br Med J. 1969; 2(5655):483-5.
PMID: 5771580
PMC: 1983431.
DOI: 10.1136/bmj.2.5655.483.
Thrombosis in coronary heart disease.
McDonald L
Br Heart J. 1968; 30(2):151-67.
PMID: 5642413
PMC: 487601.
DOI: 10.1136/hrt.30.2.151.
Platelet aggregation and the platelet release reaction in thromboembolism.
Mustard J, Packham M
Can Med Assoc J. 1970; 103(8):859-63.
PMID: 5476316
PMC: 1930539.
Prophylaxis of pulmonary embolism.
BROWSE N
Br Med J. 1970; 2(5712):780-2.
PMID: 5428746
PMC: 1700819.
DOI: 10.1136/bmj.2.5712.780.
Effect of RA233 on platelet function in vitro.
Hassanein A, Turpie A, McNicol G, Douglas A
Br Med J. 1970; 2(5701):83-6.
PMID: 5420238
PMC: 1699949.
DOI: 10.1136/bmj.2.5701.83.
Effect of dipyridamole on microaggregate formation in the pump oxygenator.
RITTENHOUSE E, Hessel 2nd E, Ito C, MERENDINO K
Ann Surg. 1972; 175(1):1-9.
PMID: 5060855
PMC: 1355149.
DOI: 10.1097/00000658-197201000-00001.
Effect in vitro on platelet function of two compounds developed from the pyrimido-pyrimidines.
Slater S, Turpie A, Douglas A, McNicol G
J Clin Pathol. 1972; 25(5):427-32.
PMID: 5046075
PMC: 477339.
DOI: 10.1136/jcp.25.5.427.
Platelet function: a review. II. Abnormal function.
Berger S
Can Med Assoc J. 1970; 102(13):1379-83.
PMID: 4912295
PMC: 1930302.
Controlled trial of dipyridamole in cerebral vascular disease.
Acheson J, Danta G, Hutchinson E
Br Med J. 1969; 1(5644):614-5.
PMID: 4885615
PMC: 1982429.
DOI: 10.1136/bmj.1.5644.614.
[Comparative animal experiment studies of the prolongation of the revival time of the heart and the whole organ in normothermia by pharmacological pretreatment].
SCHOEN H
Arch Kreislaufforsch. 1968; 57(1):1-54.
PMID: 4882072
Dipyridamole: a controlled trial of its effect in acute myocardial infarction.
GENT A, Brook C, Foley T, Miller T
Br Med J. 1968; 4(5627):366-8.
PMID: 4879059
PMC: 1912602.
DOI: 10.1136/bmj.4.5627.366.
